However, emerging evidence suggests that HER2 (human epidermal growth factor receptor 2)-amplified and high-grade hormone receptor+ luminal B tumors also exhibit a relatively high abundance of tumor-infiltrating lymphocytes, which display elevated immune checkpoint expression compared to luminal A tumors—often characterized as an immune desert [28]. This evidence concerns the gene ERBB2 and neoplasm.